BRK-B vs NCDL
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
NCDL exhibits severe fundamental deterioration, highlighted by a critical Piotroski F-Score of 0/9, indicating weakness across all health dimensions. The company is currently trading at $14.63, a significant premium to its growth-based intrinsic value of $9.10. Most concerning is the unsustainable dividend payout ratio of 138.46%, suggesting the company is returning more capital than it earns. Despite a 'Buy' analyst consensus, the combination of negative YoY EPS growth (-20%) and a bearish technical trend suggests a high-risk profile.
Compare Another Pair
Related Comparisons
BRK-B vs NCDL: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Nuveen Churchill Direct Lending Corp. (NCDL) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.